Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1998 Aug;65(2):233–240. doi: 10.1136/jnnp.65.2.233

Neuroradiological features of six kindreds with MELAS tRNALeu A3243G point mutation: implications for pathogenesis

C Sue 1, D Crimmins 1, Y Soo 1, R Pamphlett 1, C Presgrave 1, N Kotsimbos 1, M Jean-Francois 1, E Byrne 1, J Morris 1
PMCID: PMC2170193  PMID: 9703178

Abstract

OBJECTIVE—To determine the neuroradiological abnormalities associated with subjects carrying the mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS) tRNALeu(UUR) A3243G point mutation
METHODS—Mitochondrial genetic analysis was performed on 24 subjects from six kindreds with the MELAS tRNALeu(UUR) A3243G point mutation. Cerebral CT and MRI were performed on 24 patients and 15 patients respectively. Previous neuroradiological investigations including cerebral CT from four deceased members of the families were also reviewed. Histological examination of postmortem specimens of two patients within the kindreds was performed.
RESULTS—The commonest radiological finding was basal ganglia calcification. Other abnormalities included focal lesions and cerebellar and cerebral atrophy. Basal ganglia calcification was progressive, symmetric, and asymptomatic. Histologically, basal ganglia calcification in one patient was found to be in the pericapillary regions of the globus pallidus, with no neuronal involvement. Focal lesions most commonly involved the grey matter of the parietal and occipital lobes and cerebellum. Histopathological examination suggested that these were due to cellular rather than vascular dysfunction. Enlargement of the fourth ventricle was the first sign of cerebellar atrophy. Cerebral and cerebellar atrophy were only present with severe disease.
CONCLUSIONS—These radiological findings, when considered in the context of the clinical and pathological findings, seem to reflect two major disease processes: an intermittent abrupt loss of function associated with cell injury from which there is at least partial recovery and a slowly progressive degenerative process causing basal ganglia calcification, and cerebral and cerebellar atrophy. The clinical and radiological features resulting from these processes are distinctive and provide insight into the consequences of mitochondrial dysfunction on the brain.



Full Text

The Full Text of this article is available as a PDF (251.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alexander G. E., Crutcher M. D. Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci. 1990 Jul;13(7):266–271. doi: 10.1016/0166-2236(90)90107-l. [DOI] [PubMed] [Google Scholar]
  2. Allard J. C., Tilak S., Carter A. P. CT and MR of MELAS syndrome. AJNR Am J Neuroradiol. 1988 Nov-Dec;9(6):1234–1238. [PMC free article] [PubMed] [Google Scholar]
  3. Anderson H. C. Mechanisms of pathologic calcification. Rheum Dis Clin North Am. 1988 Aug;14(2):303–319. [PubMed] [Google Scholar]
  4. Barkovich A. J., Good W. V., Koch T. K., Berg B. O. Mitochondrial disorders: analysis of their clinical and imaging characteristics. AJNR Am J Neuroradiol. 1993 Sep-Oct;14(5):1119–1137. [PMC free article] [PubMed] [Google Scholar]
  5. Borle A. B. Calcium metabolism at the cellular level. Fed Proc. 1973 Sep;32(9):1944–1950. [PubMed] [Google Scholar]
  6. Chiras J., Dubs M., Bories J. Venous infarctions. Neuroradiology. 1985;27(6):593–600. doi: 10.1007/BF00340857. [DOI] [PubMed] [Google Scholar]
  7. Ciafaloni E., Ricci E., Servidei S., Shanske S., Silvestri G., Manfredi G., Schon E. A., DiMauro S. Widespread tissue distribution of a tRNALeu(UUR) mutation in the mitochondrial DNA of a patient with MELAS syndrome. Neurology. 1991 Oct;41(10):1663–1664. doi: 10.1212/wnl.41.10.1663. [DOI] [PubMed] [Google Scholar]
  8. Crimmins D., Morris J. G., Walker G. L., Sue C. M., Byrne E., Stevens S., Jean-Francis B., Yiannikas C., Pamphlett R. Mitochondrial encephalomyopathy: variable clinical expression within a single kindred. J Neurol Neurosurg Psychiatry. 1993 Aug;56(8):900–905. doi: 10.1136/jnnp.56.8.900. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. De Volder A., Ghilain S., de Barsy T., Goffinet A. M. Brain metabolism in mitochondrial encephalomyopathy: a PET study. J Comput Assist Tomogr. 1988 Sep-Oct;12(5):854–857. doi: 10.1097/00004728-198809010-00024. [DOI] [PubMed] [Google Scholar]
  10. Egger J., Kendall B. E. Computed tomography in mitochondrial cytopathy. Neuroradiology. 1981;22(2):73–78. doi: 10.1007/BF00344777. [DOI] [PubMed] [Google Scholar]
  11. Goto Y. Clinical features of MELAS and mitochondrial DNA mutations. Muscle Nerve Suppl. 1995;3:S107–S112. doi: 10.1002/mus.880181422. [DOI] [PubMed] [Google Scholar]
  12. Goto Y., Nonaka I., Horai S. A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature. 1990 Dec 13;348(6302):651–653. doi: 10.1038/348651a0. [DOI] [PubMed] [Google Scholar]
  13. Goto Y., Nonaka I., Horai S. A new mtDNA mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS). Biochim Biophys Acta. 1991 Oct 21;1097(3):238–240. doi: 10.1016/0925-4439(91)90042-8. [DOI] [PubMed] [Google Scholar]
  14. Halpern J. P., Boyages S. C., Maberly G. F., Collins J. K., Eastman C. J., Morris J. G. The neurology of endemic cretinism. A study of two endemias. Brain. 1991 Apr;114(Pt 2):825–841. doi: 10.1093/brain/114.2.825. [DOI] [PubMed] [Google Scholar]
  15. Harrington M. G., Macpherson P., McIntosh W. B., Allam B. F., Bone I. The significance of the incidental finding of basal ganglia calcification on computed tomography. J Neurol Neurosurg Psychiatry. 1981 Dec;44(12):1168–1170. doi: 10.1136/jnnp.44.12.1168. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hasegawa H., Matsuoka T., Goto Y., Nonaka I. Strongly succinate dehydrogenase-reactive blood vessels in muscles from patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes. Ann Neurol. 1991 Jun;29(6):601–605. doi: 10.1002/ana.410290606. [DOI] [PubMed] [Google Scholar]
  17. Hasuo K., Tamura S., Yasumori K., Uchino A., Goda S., Ishimoto S., Kamikaseda K., Wakuta Y., Kishi M., Masuda K. Computed tomography and angiography in MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes); report of 3 cases. Neuroradiology. 1987;29(4):393–397. doi: 10.1007/BF00348922. [DOI] [PubMed] [Google Scholar]
  18. Kendall B. E. Disorders of lysosomes, peroxisomes, and mitochondria. AJNR Am J Neuroradiol. 1992 Mar-Apr;13(2):621–653. [PMC free article] [PubMed] [Google Scholar]
  19. Kingsley D. P., Kendall B. E. CT of the adverse effects of therapeutic radiation of the central nervous system. AJNR Am J Neuroradiol. 1981 Sep-Oct;2(5):453–460. [PMC free article] [PubMed] [Google Scholar]
  20. Kishi M., Yamamura Y., Kurihara T., Fukuhara N., Tsuruta K., Matsukura S., Hayashi T., Nakagawa M., Kuriyama M. An autopsy case of mitochondrial encephalomyopathy: biochemical and electron microscopic studies of the brain. J Neurol Sci. 1988 Aug;86(1):31–40. doi: 10.1016/0022-510x(88)90005-6. [DOI] [PubMed] [Google Scholar]
  21. Koller W. C., Cochran J. W., Klawans H. L. Calcification of the basal ganglia: computerized tomography and clinical correlation. Neurology. 1979 Mar;29(3):328–333. doi: 10.1212/wnl.29.3.328. [DOI] [PubMed] [Google Scholar]
  22. Kotsimbos N., Jean-Francois M. J., Huizing M., Kapsa R. M., Lertrit P., Siregar N. C., Marzuki S., Sue C., Byrne E. Rapid and noninvasive screening of patients with mitochondrial myopathy. Hum Mutat. 1994;4(2):132–135. doi: 10.1002/humu.1380040207. [DOI] [PubMed] [Google Scholar]
  23. Kuriyama M., Umezaki H., Fukuda Y., Osame M., Koike K., Tateishi J., Igata A. Mitochondrial encephalomyopathy with lactate-pyruvate elevation and brain infarctions. Neurology. 1984 Jan;34(1):72–77. doi: 10.1212/wnl.34.1.72. [DOI] [PubMed] [Google Scholar]
  24. Lauritzen M., Skyhøj Olsen T., Lassen N. A., Paulson O. B. Changes in regional cerebral blood flow during the course of classic migraine attacks. Ann Neurol. 1983 Jun;13(6):633–641. doi: 10.1002/ana.410130609. [DOI] [PubMed] [Google Scholar]
  25. Lertrit P., Noer A. S., Jean-Francois M. J., Kapsa R., Dennett X., Thyagarajan D., Lethlean K., Byrne E., Marzuki S. A new disease-related mutation for mitochondrial encephalopathy lactic acidosis and strokelike episodes (MELAS) syndrome affects the ND4 subunit of the respiratory complex I. Am J Hum Genet. 1992 Sep;51(3):457–468. [PMC free article] [PubMed] [Google Scholar]
  26. Love S., Nicoll J. A., Kinrade E. Sequencing and quantitative assessment of mutant and wild-type mitochondrial DNA in paraffin sections from cases of MELAS. J Pathol. 1993 May;170(1):9–14. doi: 10.1002/path.1711700103. [DOI] [PubMed] [Google Scholar]
  27. Mathews P. M., Andermann F., Silver K., Karpati G., Arnold D. L. Proton MR spectroscopic characterization of differences in regional brain metabolic abnormalities in mitochondrial encephalomyopathies. Neurology. 1993 Dec;43(12):2484–2490. doi: 10.1212/wnl.43.12.2484. [DOI] [PubMed] [Google Scholar]
  28. Matsuoka T., Hasegawa H., Nonaka I. [Strongly succinate dehydrogenase-reactive blood vessels (SSV) in various neuromuscular diseases]. Rinsho Shinkeigaku. 1992 Jun;32(6):645–647. [PubMed] [Google Scholar]
  29. Messimy R., Diebler C., Metzger J. Dystonie de torsion du membre supérieur gauche probablement consécutive a un traumatisme cranien. Calcification de la tête du noyau caudé droit découverte à l'examen tomodensitométrique. Rev Neurol (Paris) 1977 Mar;133(3):199–206. [PubMed] [Google Scholar]
  30. Midroni G., Willinsky R. Rapid postanoxic calcification of the basal ganglia. Neurology. 1992 Nov;42(11):2144–2146. doi: 10.1212/wnl.42.11.2144. [DOI] [PubMed] [Google Scholar]
  31. Morita K., Ono S., Fukunaga M., Yasuda T., Higashi Y., Terao A., Morita R. Increased accumulation of N-isopropyl-p-(123I)-iodoamphetamine in two cases with mitochondrial encephalomyopathy with lactic acidosis and strokelike episodes (MELAS). Neuroradiology. 1989;31(4):358–361. doi: 10.1007/BF00344185. [DOI] [PubMed] [Google Scholar]
  32. Muenter M. D., Whisnant J. P. Basal ganglia calcification, hypoparathyroidism, and extrapyramidal motor manifestations. Neurology. 1968 Nov;18(11):1075–1083. doi: 10.1212/wnl.18.11.1075. [DOI] [PubMed] [Google Scholar]
  33. Olesen J., Larsen B., Lauritzen M. Focal hyperemia followed by spreading oligemia and impaired activation of rCBF in classic migraine. Ann Neurol. 1981 Apr;9(4):344–352. doi: 10.1002/ana.410090406. [DOI] [PubMed] [Google Scholar]
  34. Ooiwa Y., Uematsu Y., Terada T., Nakai K., Itakura T., Komai N., Moriwaki H. Cerebral blood flow in mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes. Stroke. 1993 Feb;24(2):304–309. doi: 10.1161/01.str.24.2.304. [DOI] [PubMed] [Google Scholar]
  35. Pavlakis S. G., Phillips P. C., DiMauro S., De Vivo D. C., Rowland L. P. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: a distinctive clinical syndrome. Ann Neurol. 1984 Oct;16(4):481–488. doi: 10.1002/ana.410160409. [DOI] [PubMed] [Google Scholar]
  36. Petty R. K., Harding A. E., Morgan-Hughes J. A. The clinical features of mitochondrial myopathy. Brain. 1986 Oct;109(Pt 5):915–938. doi: 10.1093/brain/109.5.915. [DOI] [PubMed] [Google Scholar]
  37. Reynolds S. F., Blass J. A possible mechanism for selective cerebellar damage in partial pyruvate dehydrogenase deficiency. Neurology. 1976 Jul;26(7):625–628. doi: 10.1212/wnl.26.7.625. [DOI] [PubMed] [Google Scholar]
  38. Rosen L., Phillips S., Enzmann D. Magnetic resonance imaging in MELAS syndrome. Neuroradiology. 1990;32(2):168–171. doi: 10.1007/BF00588572. [DOI] [PubMed] [Google Scholar]
  39. SLAGER U. T., WAGNER J. A. The incidence, composition, and pathological significance of intracerebral vascular deposits in the basal ganglia. J Neuropathol Exp Neurol. 1956 Oct;15(4):417–431. doi: 10.1097/00005072-195610000-00005. [DOI] [PubMed] [Google Scholar]
  40. Sakuta R., Nonaka I. Vascular involvement in mitochondrial myopathy. Ann Neurol. 1989 Jun;25(6):594–601. doi: 10.1002/ana.410250611. [DOI] [PubMed] [Google Scholar]
  41. Satoh M., Ishikawa N., Yoshizawa T., Takeda T., Akisada M. N-isopropyl-p-[123I]iodoamphetamine SPECT in MELAS syndrome: comparison with CT and MR imaging. J Comput Assist Tomogr. 1991 Jan-Feb;15(1):77–82. doi: 10.1097/00004728-199101000-00010. [DOI] [PubMed] [Google Scholar]
  42. Schon E. A., Rizzuto R., Moraes C. T., Nakase H., Zeviani M., DiMauro S. A direct repeat is a hotspot for large-scale deletion of human mitochondrial DNA. Science. 1989 Apr 21;244(4902):346–349. doi: 10.1126/science.2711184. [DOI] [PubMed] [Google Scholar]
  43. Shoffner J. M., Lott M. T., Lezza A. M., Seibel P., Ballinger S. W., Wallace D. C. Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNA(Lys) mutation. Cell. 1990 Jun 15;61(6):931–937. doi: 10.1016/0092-8674(90)90059-n. [DOI] [PubMed] [Google Scholar]
  44. Shoji Y., Sato W., Hayasaka K., Takada G. Tissue distribution of mutant mitochondrial DNA in mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS). J Inherit Metab Dis. 1993;16(1):27–30. doi: 10.1007/BF00711311. [DOI] [PubMed] [Google Scholar]
  45. Silvestri G., Moraes C. T., Shanske S., Oh S. J., DiMauro S. A new mtDNA mutation in the tRNA(Lys) gene associated with myoclonic epilepsy and ragged-red fibers (MERRF). Am J Hum Genet. 1992 Dec;51(6):1213–1217. [PMC free article] [PubMed] [Google Scholar]
  46. Taverni N., Dal Pozzo G., Arnetoli G., Zappoli R. Diagnosis and follow-up of mitochondrial encephalomyopathy: CT and MR studies. J Comput Assist Tomogr. 1988 Jul-Aug;12(4):696–697. doi: 10.1097/00004728-198807000-00042. [DOI] [PubMed] [Google Scholar]
  47. Tokunaga M., Mita S., Sakuta R., Nonaka I., Araki S. Increased mitochondrial DNA in blood vessels and ragged-red fibers in mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS). Ann Neurol. 1993 Mar;33(3):275–280. doi: 10.1002/ana.410330308. [DOI] [PubMed] [Google Scholar]
  48. Toppet M., Telerman-Toppet N., Szliwowski H. B., Vainsel M., Coers C. Oculocraniosomatic neuromuscular disease with hypoparathyroidism. Am J Dis Child. 1977 Apr;131(4):437–441. doi: 10.1001/archpedi.1977.02120170063012. [DOI] [PubMed] [Google Scholar]
  49. Trounce I., Byrne E., Marzuki S. Decline in skeletal muscle mitochondrial respiratory chain function: possible factor in ageing. Lancet. 1989 Mar 25;1(8639):637–639. doi: 10.1016/s0140-6736(89)92143-0. [DOI] [PubMed] [Google Scholar]
  50. Yamamoto T., Beppu H., Tsubaki T. Mitochondrial encephalomyopathy: fluctuating symptoms and CT. Neurology. 1984 Nov;34(11):1456–1460. doi: 10.1212/wnl.34.11.1456. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES